Cancer Letters
Volume 286, Issue 2 , Pages 240-249 , 28 December 2009

p27-Associated G1 arrest induced by hinokitiol in human malignant melanoma cells is mediated via down-regulation of pRb, Skp2 ubiquitin ligase, and impairment of Cdk2 function

  • Shicheng Liu

      Affiliations

    • Corresponding Author InformationCorresponding author. Address: Research Department, Research and Development Department, Nipro Patch Co., Ltd., 8-1, Minamisakae-cho, Kasukabe, Saitama 344-0057, Japan. Tel.: +81 48 763 8622; fax: +81 48 763 8668.
    • ,
  • Hitoshi Yamauchi

Received 30 April 2009 ,Revised 27 May 2009 ,Accepted 27 May 2009.

References 

  1. Gray-Schopfer VC, Karasarides M, Hayward R, Marais R. Tumor necrosis factor-alpha blocks apoptosis in melanoma cells when BRAF signaling is inhibited. Cancer Res. 2007;67:122–129
  2. Amiri KI, Horton LW, LaFleur BJ, Sosman LA, Richmond A. Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma. Cancer Res. 2004;64:4912–4918
  3. Hacker E, Muller HK, Irwin N, Gabrielli B, Lincoln D, Pavey S, et al. Spontaneous and UV radiation-induced multiple metastatic melanomas in Cdk4R24C/R24C/TPras mice. Cancer Res. 2006;66:2946–2952
  4. Jiang W, Mikochik PJ, Ra JH, Lei H, Flaherty KT, Winkler JD, et al. HIV protease inhibitor nelfinavir inhibits growth of human melanoma cells by induction of cell cycle arrest. Cancer Res. 2007;67:1221–1227
  5. Lee KW, Kim HJ, Lee YS, Park HJ, Choi JW, Ha J, et al. Acteoside inhibits human promyelocytic HL-60 leukemia cell proliferation via inducing cell cycle arrest at G0/G1 phase and differentiation into monocyte. Carcinogenesis. 2007;28:1928–1936
  6. Ekholm SV, Reed SI. Regulation of G1 cyclin-dependent kinases in the mammalian cell cycle. Curr. Opin. Cell Biol. 2000;12:676–684
  7. Sherr CJ, Roberts JM. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 1999;13:501–1512
  8. Graña X, Reddy EP. Cell cycle control in mammalian cells: role of cyclins, cyclin dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs). Oncogene. 1995;11:211–219
  9. Liu S, Yamauchi H. Hinokitiol, a metal chelator derived from natural plants, suppresses cell growth and disrupts androgen receptor signaling in prostate carcinoma cell lines. Biochem. Biophys. Res. Commun. 2006;351:26–32
  10. Inamori Y, Tsujibo H, Ohishi H, Ishii F, Mizugaki M, Aso H, et al. Cytotoxic effect of hinokitiol and tropolone on the growth of mammalian cells and on blastogenesis of mouse splenic T cells. Biol. Pharm. Bull. 1993;16:521–523
  11. Baba T, Nakano H, Tamai K, Sawamura D, Hanada K, Hashimoto I, et al. Inhibitory effect of beta-thujaplicin on ultraviolet B-induced apoptosis in mouse keratinocytes. J. Invest. Dermatol. 1998;110:24–28
  12. Muto N, Dota A, Tanaka T, Itoh N, Okabe M, Inada A, et al. Hinokitiol induces differentiation of Teratocarcinoma F9 cells. Biol. Pharm. Bull. 1995;18:576–1579
  13. Ohta Y, Kijima H, Ohkawa T, Kashani-Sabet M, Scanlon KJ. Tissue-specific expression of an anti-ras ribozyme inhibits proliferation of human malignant melanoma cells. Nucleic Acids Res. 1996;24:938–942
  14. Verhaegen M, Bauer JA, Martín de la Vega C, Wang G, Wolter KG, Brenner JC, et al. A novel BH3 mimetic reveals a mitogen-activated protein kinase-dependent mechanism of melanoma cell death controlled by p53 and reactive oxygen species. Cancer Res. 2006;66:11348–11359
  15. Liu S, Yamauchi H. Different patterns of 5alpha-reductase expression, cellular distribution, and testosterone metabolism in human follicular dermal papilla cells. Biochem. Biophys. Res. Commun. 2008;368:858–864
  16. Liu S, Mizu H, Yamauchi H. Molecular response to phototoxic stress of UVB-irradiated ketoprofen through arresting cell cycle in G2/M phase and inducing apoptosis. Biochem. Biophys. Res. Commun. 2007;364:650–655
  17. Ling YH, Li T, Yuan Z, Haigentz M, Weber TK, Perez-Soler R. Erlotinib, an effective epidermal growth factor receptor tyrosine kinase inhibitor induces p27KIP1 up-regulation and nuclear translocation in association with cell growth inhibition and G1/S phase arrest in human non-small-cell lung cancer cell lines. Mol. Pharmacol. 2007;72:248–258
  18. Ukomadu C, Dutta A. p21-Dependent inhibition of colon cancer cell growth by mevastatin is independent of inhibition of G1 cyclin-dependent kinases. J. Biol. Chem. 2003;278:43586–43594
  19. Machida YI, Teer JK, Dutta A. Acute reduction of an origin recognition complex (ORC) subunit in human cells reveals a requirement of ORC for Cdk2 activation. J. Biol. Chem. 2005;280:27624–27630
  20. Saxena S, Jónsson ZO, Dutta A. Small RNAs with imperfect match to endogenous mRNA repress translation. Implications for off-target activity of small inhibitory RNA in mammalian cells. J. Biol. Chem. 2003;278:44312–44319
  21. Weinberg RA. The retinoblastoma protein and cell cycle control. Cell. 1995;81:323–330
  22. Albino AP, Juan G, Traganos F, Reinhart L, Connolly J, Rose DR, et al. Cell cycle arrest and apoptosis of melanoma cells by docosahexaenoic acid: association with decreased pRb phosphorylation. Cancer Res. 2000;60:4139–4145
  23. Roy S, Kaur M, Agarwal C, Tecklenburg M, Sclafani RA, Agarwal R. p21 and p27 induction by silibinin is essential for its cell cycle arrest effect in prostate carcinoma cells. Mol. Cancer Ther. 2007;6:2696–2707
  24. Molinari M. Cell cycle checkpoints and their inactivation in human cancer. Cell Prolif. 2000;33:261–274
  25. Xu K, Belunis C, Chu W, Weber D, Podlaski F, Huang KS, et al. Protein–protein interactions involved in the recognition of p27 by E3 ubiquitin ligase. Biochem. J. 2003;371:957–964
  26. Tsvetkov LM, Yeh KH, Lee SJ, Sun H, Zhang H. p27 (Kip1) ubiquitination and degradation is regulated by the SCF(Skp2) complex through phosphorylation Thr187 in p27. Curr. Biol. 1999;9:661–664
  27. Jackman M, Kubota Y, den Elzen N, Hagting A, Pines J. Cyclin A– and cyclin E–Cdk complexes shuttle between the nucleus and the cytoplasm. Mol. Biol. Cell. 2002;13:1030–1045
  28. Obaya AJ, Sedivy JM. Regulation of cyclin–Cdk activity in mammalian cells. Cell. Mol. Life Sci. 2002;59:126–142
  29. Yang ES, Burnstein KI. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J. Biol. Chem. 2003;278:46862–46868
  30. Huang H, Regan KM, Wang F, Wang D, Smith DI, van Deursen JM, et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl. Acad. Sci. USA. 2005;102:1649–1654
  31. Sonoda H, Inoue H, Ogawa K, Utsunomiya T, Masuda TA, Mori M. Significance of skp2 expression in primary breast cancer. Clin. Cancer Res. 2006;12:1215–1220
  32. Lin R, Wang TT, Miller WH, White JH. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Endocrinology. 2003;144:749–753
  33. Huang HC, Way TD, Lin CL, Lin JK. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein. Endocrinology. 2008;149:5972–5983

PII: S0304-3835(09)00395-4

doi: 10.1016/j.canlet.2009.05.038

Cancer Letters
Volume 286, Issue 2 , Pages 240-249 , 28 December 2009

Article Tools

* Image Usage & Resolution